1. Introduction {#s0005}
===============

*Vibrio parahaemolyticus* is a facultative, anaerobic, Gram-negative, curved rod-shaped bacterium commonly found in marine and estuary environments. It is a moderate halophilic bacterium capable of survival and multiplication at a concentration of 1 to 9% sodium chloride (NaCl) while the optimal growth happens at 3% NaCl ([@b0270], [@b0110]). The ecological habitat of *V. parahaemolyticus* can be free to live as bacterioplankton, associated with the seafood surface, and a parasite in the gastrointestinal tract of fish. Higher organisms such as crustacean and molluscan shellfish are frequently found to be associated with *V. parahaemolyticus* ([@b0125], [@b0130], [@b0165], [@b0160], [@b0295]). Shellfish and other aquatic organisms are therefore often used as a vehicle for the transmission of this microorganism. Although *V. parahaemolyticus* is a well-known halophile, some reports have shown that *V. parahaemolyticus* can also be found in freshwater organisms ([@b0180], [@b0185], [@b0195], [@b0205]).

Ingestion of food contaminated with *V. parahaemolyticus* can lead to gastrointestinal illness, including symptoms such as watery diarrhoea, abdominal cramps, nausea, vomiting, fever, headache and/or bloody diarrhoea ([@b0045]). Open wounds in contact with *V. parahaemolyticus* may also result in wound infection and life-threatening septicemia. Based on the number of vibriosis infections reported to the Cholera and Other Vibrio Illness Surveillance (COVIS) system and Centers for Disease Control and Prevention (CDC) from 1996 to 2014, *V. parahaemolyticus* was identified as the most common foodborne pathogen which caused 39--51% of *Vibrio* infection compared to other *Vibrio* species such as *V. vulnificus*, *V. cholerae* (non-O1 and non-O139), *V. alginolyticus*, *V. fluvialis*, *V. mimicus*, and *V. hollisae* ([@b0190], [@b0050]). The high infection rate caused by *V. parahaemolyticus* results in high medical costs worldwide. For example, the annual health cost of ingestion of seafood contaminated with *V. parahaemolyticus* in the United States was estimated to be \$21 million ([@b0215]).

Another global health concern in recent years has been the rising cost of the medical costs of antibiotic-resistant infections. Timely surveillance of antibiotic-resistant bacteria and dissemination of surveillance data are therefore essential to address these public health issues ([@b0090]). Antibiotic resistance profiles of bacteria are usually determined through phenotypic assays such as agar dilution, broth dilution and Kirby-Bauer disk diffusion. Agar and broth dilution methods are used to determine the minimal inhibitory concentration (MIC) of antimicrobial agents by inoculating the defined number of bacterial cells at different concentrations of the antimicrobial substance ([@b0275]). Kirby-Bauer disk diffusion method involves different kinds of the antibiotic disc placed on a bacterium agar plate and the antimicrobial profile of the bacteria is interpreted as sensitive, intermediate and resistance based on the inhibition zone. This latter method is routinely used in many clinical microbiology laboratories to test common and fast-growing pathogens due to its simplicity, well standardized, and easily interpreted ([@b0105], [@b0250]).

The majority of *V. parahaemolyticus* strains isolated from clinical and environmental samples reported high resistance to multiple antibiotics such as amoxicillin, ampicillin, carbenicillin, cefazolin, ceftazidime, cephalothin, colistin, gentamicin, and tobramycin ([@b0300], [@b0060], [@b0010], [@b0240], [@b0290]). Extensive use and misuse of prophylactic antibiotics in aquaculture for the prevention of bacterial infection and rapid spread of disease is most likely the main cause of the emergence and widespread of multiple drug resistance (MDR) in *V. parahaemolyticus* isolates. In addition, the overuse of antibiotics in aquaculture not only increases the selection of antibiotic-resistant bacteria and the dissemination of the antibiotic-resistant genes but also results in the presence of antibiotic residues in aquatic organisms such as fish ([@b0175]). The presence of *V. parahaemolyticus* in seafood samples and the occurrence of *V. parahaemolyticus* antibiotic resistance should be evaluated frequently. The aim of this study was to determine the prevalence and antibiotic-resistant patterns of *V. parahaemolyticus* isolated from different types of seafood in Malaysia.

2. Materials and methods {#s0010}
========================

2.1. Sample collection {#s0015}
----------------------

A total of 140 seafood samples consists of 35 samples for each blood clam (*Anadara granosa*), shrimp (*Penaeus* spp.), surf clam (*Paphia undulata*), and squid (*Loligo* spp.) were purchased from different wet markets in Selangor, Malaysia, for a period of 6 months from January 2018 to June 2018. All samples were transported to the laboratory and analysed immediately on the same sampling date.

2.2. Enrichment and isolation {#s0020}
-----------------------------

Samples were examined according to the US FDA Bacteriological Analytical Manual (BAM) for *Vibrio* species with some modifications ([@b0115]). Twenty-five grams of each sample was weighed and transferred to a sterile stomacher bag containing 225 mL of alkaline peptone water (APW; Merck, Germany). Sample in the stomacher bag was mixed with Stomacher Lab-Blender 400 (Seward Medical, UK) for 2 min. Serial 10-fold dilution was carried out up to 10^−5^ by transferring 1 mL of the mixture to 9 mL of APW. Each dilution tube in triplicate was incubated at 37 °C overnight. After incubation, one loopful of the sample in each tube was streaked onto the CHROMagar™ *Vibrio* (CV) plate and the plates were incubated at 37 °C for overnight. Bacterial colonies in mauve colour were considered to be presumptive *V. parahaemolyticus*. The mauve colony was picked, purified by streaking back onto the CV plate and incubated at 37 °C overnight. A single colony was transferred to tryptic soy broth (TSB; Merck, Germany) supplemented by 2.5% NaCl (Merck, Germany) and incubated at 37 °C overnight. Colonies growth in the TSB were subjected to DNA extraction and *V. parahaemolyticus* species-specific confirmation through PCR assay. Pure *V. parahaemolyticus* colonies were stored on tryptic soy agar (TSA; Merck, Germany) slanted and kept at room temperature until further analysis.

2.3. DNA extraction and PCR confirmation {#s0025}
----------------------------------------

Bacterial DNA extraction was done by boiling and freeze-thawing extraction procedures. Briefly, 1.5 mL of overnight culture growth in the TSB supplemented by 2.5% NaCl was centrifuged at 13,400 × *g* for 3 min. The supernatant was discarded and the pellet was suspended in 200 µL TE buffer (10 mM Tris-HCl and 1 mM EDTA•Na~2~ at pH 8.0). The suspension was boiled at 100 °C for 15 min in a dry bath (Labnet, USA) and immediately kept in a −20 °C freezer for 15 min. The suspension was then again centrifuged at 13,400 × g for 1 min and the supernatant was used as a DNA template for the PCR assay.

Presumptive *V. parahaemolyticus* colony growth on the CV plate was confirmed by amplification of *V. parahaemolyticus* species-specific gene with the *toxR* primers (F: 5′-GTCTTCTGACGCAATCGTTG-3′ and R: 5′-ATACGAGTGGTTGCTGTCATG-3′) ([@b0120]). The presence of thermostable direct hemolysin (TDH) and TDH-related hemolysin (TRH) genes was also detected by the use of the *tdh* primers (F: 5′-CCACTACCACTCTCATATGC-3′ and R: 5′-GGTACTAAATGGCTGACATC-3′) and *trh* primers (F: 5′-TTGGCTTCGATATTTTCAGTATCT-3′ and R: 5′-CATAACAAACATATGCCCATTTCCG-3′), respectively ([@b0255], [@b0025]). The amplification of *toxR*, *tdh* and *trh* genes was performed in a single reaction according to the multiplex PCR procedure described by [@b0165].

A total of 25 µL of each reaction mixture consists of 7 µL of 1.4 × PCR buffer, 2.5 µL of 2.5 mM MgCl~2~, 0.5 µL of 0.2 mM dNTPs, 0.5 µL of 0.2 μM primers mix, 0.4 µL of GoTaq® Taq polymerase (Promega, USA), 2 μL of DNA template, and 12.1 µL of sterilized distilled water. The amplification was performed in the Kyratec SuperCycler Trinity (Australia) and the following conditions were applied: initial denaturation at 95 °C for 5 min for 1 cycle, 30 cycles consisting of denaturation at 95 °C for 30 s, annealing at 60 °C for 45 s, extension at 68 °C for 1 min, and final extension cycle at 72 °C for 3 min.

2.4. Antibiotic susceptibility test (AST) {#s0030}
-----------------------------------------

A single *V. parahaemolyticus* isolate from each positive sample was selected for the antibiotic susceptibility test. A total of 24 types of antibiotics including amikacin (30 μg), amoxicillin-clavulanic acid (20/10 μg), ampicillin (10 μg), ampicillin-sulbactam (10 μg), cefazolin (30 μg), cefepime (30 μg), cefotaxime (30 μg), cefoxitin (30 μg), ceftazidime (30 μg), cefuroxime sodium (parenteral) (30 μg), cephalothin (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), doxycycline (30 μg), gentamicin (10 μg), imipenem (10 μg), levofloxacin (5 μg), meropenem (10 μg), ofloxacin (5 μg), penicillin G (10 unit), piperacillin (100 μg), piperacillin-tazobactam (100/10 μg), tetracycline (30 μg), and trimethoprim-sulfamethoxazole (1.25/23.75 μg) was used in this study. All the antimicrobial susceptibility discs were purchased from Oxoid (England). Selection of antibiotics was based on their frequent usage in clinical practices and according to the Clinical and Laboratory Standards Institute (CLSI) M45 guideline for *Vibrio* spp. (not V*. cholerae*) ([@b0055]). Disk susceptibility testing was according to the Kirby-Bauer disk diffusion method and CLSI M45 guidelines ([@b0020], [@b0055]).

Briefly, a direct colony suspension was prepared by suspending the bacterial colony in 0.85% NaCl solution and adjusting equivalent to 0.5 McFarland standard. The inoculum was swabbed uniformly on the Mueller-Hinton agar plate (MHA; Merck, Germany) using a sterile cotton swab and allowed to dry for 5--10 min before placing the antibiotic disks on the MHA plate by using Oxoid™ disk dispenser. The plates were then incubated at 35 °C for 16--20 h. *Escherichia coli* ATCC® 25922 was included and used as a quality control organism in this study to monitor the accuracy of disk diffusion tests.

2.5. AST interpretive criteria {#s0035}
------------------------------

The diameter of any inhibition zone around the antibiotic disk was measured in the nearest millimetre. The zone diameter value was used to categorize each isolate as susceptible, intermediate, and resistant according to the CLSI recommendation breakpoint ([@b0055]). The multiple antibiotic resistance (MAR) index was also determined by using the formula, a/b, where "a" is the number of antibiotics to which the particular isolate was resistant, and "b" is the total number of antibiotics tested ([@b0135]).

3. Results {#s0040}
==========

3.1. Prevalence of *V. parahaemolyticus* {#s0045}
----------------------------------------

A total of 120 (85.71%) samples were found to be positive for *V. parahaemolyticus*. *V. parahaemolyticus* was isolated from 91.43% (32/35) of blood clams, 88.57% (31/35) of shrimps, 82.86% (29/35) of surf clams, and 80% (28/35) of squids. The prevalence of *V. parahaemolyticus* in four different types of seafood samples is summarised in [Table 1](#t0005){ref-type="table"}. A 368 bp DNA fragment was developed from the PCR assay detection of *V. parahaemolyticus* species-specific *toxR* gene ([Fig. 1](#f0005){ref-type="fig"}). None of the *V. parahaemolyticus* isolates isolated from seafood samples were positive for pathogenic *tdh* and *trh* genes.Table 1Prevalence of *Vibrio parahaemolyticus* in blood clam, shrimp, surf clam and squid.SampleNo. of sampleNumber of positive samples(%) of positive samplesBlood clam353291.43Shrimp353188.57Surf clam352982.86Squid352880.00Total14012085.71Fig. 1Agarose gel electrophoresis of PCR products. M = 100 bp DNA marker; Lane 1: blood clam sample with *toxR* positive; Lane 2: shrimp sample with *toxR* positive; Lane 3: surf clam sample with *toxR* positive; Lane 4: squid sample with *toxR* positive; Lane 5: positive control; Lane 6: negative control.

3.2. Antibiotic susceptibility test (AST) {#s0050}
-----------------------------------------

A total of 120 *V. parahaemolyticus* isolates collected from all positive samples were confirmed by a pre-tested PCR assay against 24 types of antibiotics. Antibiotic susceptibility profiles of 120 *V. parahaemolyticus* isolates are presented in [Table 2](#t0010){ref-type="table"}. All the *V. parahaemolyticus* isolates are 100% penicillin G resistant. The majority of *V. parahaemolyticus* (84.17%) isolated from seafood samples were also found to be highly resistant to ampicillin and cefazolin. Antibiotic sensitivity profiles of *V. parahaemolyticus* have shown that chloramphenicol inhibits the growth of all isolates. Ampicillin-sulbactam, imipenem, meropenem, tetracycline, trimethoprim-sulfamethoxazole, and doxycycline were also found to be effective against more than 90% of *V. parahaemolyticus* isolates. The antibiotic resistance profile of each *V. parahaemolyticus* was found to differ with MAR indices ranging from 0.04 to 0.71 ([Table 3](#t0015){ref-type="table"}). The BC4 isolate showed the highest MAR index of 0.71 that was resistant to 17 antibiotics. In this study, majority of *V. parahaemolyticus* isolates from seafood samples demonstrated resistance to at least 3 antibiotics.Table 2Antibiotic susceptibility profiles of *V. parahaemolyticus* isolated from seafood samples tested by disk diffusion method.AntibioticsCodeInterpretive criteriaResistant (%)Intermediate (%)Sensitivity (%)Amikacin (30ug)Ak45 (37.50)40 (33.33)35 (29.17)Amoxicillin-clavulanic acid (20/10ug)Amc1 (0.83)28 (23.33)91 (75.83)Ampicillin (10ug)Amp101 (84.17)13 (10.83)6 (5.00)Ampicillin-sulbactam (10ug)Sam1 (0.83)7 (5.83)112 (93.33)Cefazolin (30ug)Cz101 (84.17)17 (14.17)2 (1.67)Cefepime (30ug)Fep4 (3.33)30 (25.00)86 (71.67)Cefotaxime (30ug)Ctx6 (5.00)72 (60.00)42 (35.00)Cefoxitin (30ug)Fox15 (12.50)57 (47.50)48 (40.00)Ceftazidime (30ug)Caz6 (5.00)29 (24.17)85 (70.83)Cefuroxime sodium (parental) (30ug)Cxm62 (51.67)45 (37.50)13 (10.83)Cephalothin (30ug)Kf65 (54.17)43 (35.83)12 (10.00)Chloramphenicol (30ug)C----120 (100)Ciprofloxacin (5ug)Cip16 (13.33)80 (66.67)24 (20.00)Doxycycline (30ug)Do--2 (1.67)118 (98.33)Gentamicin (10ug)Cn8 (6.67)35 (29.17)77 (64.17)Imipenem (10ug)Ipm--2 (1.67)118 (98.33)Levofloxacin (5ug)Lev2 (1.67)30 (25.00)88 (73.33)Meropenem (10ug)Mem--2 (1.67)118 (98.33)Ofloxacin (5ug)Ofx3 (2.50)33 (27.50)84 (70.00)Penicillin G (10 unit)P120 (100)----Piperacillin (100ug)Prl43 (35.83)28 (23.33)49 (40.83)Piperacillintazobactam (100/10ug)Tzp19 (15.83)35 (29.17)66 (55.00)Tetracyline (30ug)Te--7 (5.83)113 (94.17)Trimethoprimsulfamethoxazole (1.25/23.75ug)Sxt--6 (5.00)114 (95.00)Table 3Antibiotics resistance profile and multiple antibiotic resistance (MAR) index of *V. parahaemolyticus* isolated from seafood samples.MAR IndexAntibiotics Resistance ProfileIsolates[a](#tblfn1){ref-type="table-fn"}Percentage of Isolate (%)0.71Amp, Amc, Sam, Prl, Tzp, Cz, Fep, Ctx, Fox, Cxm, Kf, Ak, Cn, Cip, Lev, Ofx, PBC40.830.63Amp, Prl, Tzp, Cz, Fep, Ctx, Fox, Caz, Cxm, Kf, Ak, Cip, Lev, Ofc, PSC20.830.58Amp, Prl, Tzp, Cz, Ctx, Fox, Caz, Cxm, Kf, Ak, Cn, Cip, Ofx, PSQ30.830.54Amp, Prl, Tzp, Cz, Fep, Ctx, Fox, Caz, Cxm, Kf, Ak, Cip, PBC100.830.50Amp, Prl, Tzp, Cz, Fep, Ctx, Fox, Cxm, Kf, Ak, Cip, PSH30.830.46Amp, Prl, Tzp, Cz, Fox, Cxm, Kf, Ak, Cn, Cip, PBC16, SH191.670.42Amp, Prl, Tzp, Cz, Cxm, Kf, Ak, Cn, Cip, PSQ13, SH201.670.38Amp, Prl, Tzp, Cz, Fox, Caz, Cxm, Kf, P\
Amp, Prl, Tzp, Cz, Cxm, Kf, Ak, Cip, P\
Amp, Prl, Tzp, Cz, Cxm, Kf, Ak, Cn, P\
Amp, Prl, Cz, Ctx, Fox, Cxm, Kf, Ak, PSH2\
BC1\
SQ4\
SC150.83\
0.83\
0.83\
0.830.33Amp, Cz, Fox, Cxm, Kf, Ak, Cip, P\
Amp, Prl, Tzp, Cz, Cxm, Kf, Cip, P\
Amp, Prl, Tzp, Cz, Cxm, Kf, Ak, P\
Amp, Prl, Tzp, Cz, Fox, Cxm, Kf, P\
Amp, Prl, Tzp, Cz, Caz, Cxm, Kf, P\
Amp, Prl, Cz, Cxm, Kf, Ak, Cn, PSH1\
SC3\
SC11\
SC12\
BC13\
SC190.83\
0.83\
0.83\
0.83\
0.83\
0.830.29Amp, Prl, Cz, Fox, Cxm, Kf, P\
Amp, Prl, Cz, Cxm, Kf, Cip, P\
Amp, Prl, Tzp, Cz, Cxm, Kf, P\
Amp, Cz, Cxm, Kf, Ak, Cip, P\
Amp, Prl, Cz, Cxm, Kf, Ak, P\
\
BC3\
BC29\
SQ2, BC2, SQ7\
SH9, SQ21, BC30\
SH4, SH5, BC12, SQ4, SH18, SQ15, SQ23, BC230.83\
0.83\
2.50\
2.50\
6.670.25Amp, Cz, Cxm, Kf, Cip, P\
Amp, Prl, Cz, Cxm, Ak, P\
Amp, Cz, Caz, Cxm, Kf, P\
Amp, Prl, Cz, Fox, Ak, P\
Amp, Cz, Fox, Cxm, Kf, P\
Amp, Prl, Cz, Cxm, Kf, P\
Amp, Prl, Cz, Cxm, Ak, P\
Amp, Cz, Cxm, Kf, Ak, PSQ1\
SQ5\
SC13\
SH13\
SQ10, BC22\
SC17, SQ22\
SH16, SH17\
SH11, SH14, SH15, SH25, SH28, SC24, SC260.83\
0.83\
0.83\
0.83\
1.67\
1.67\
1.67\
5.830.21Amp, Prl, Cz, Ak, P\
Amp, Cz, Cxm, Ak, P\
Amp, Cz, Kf, Ak, P\
Amp, Cz, Cxm, Kf, PSQ11, SQ24\
BC17, BC32\
SH6, SQ6, SQ26\
SC1, BC5, SQ8, SC10, SQ12, BC25, BC27, SC291.67\
1.67\
2.50\
6.670.17Amp, Cz, Ak, P\
Amp, Cz, Kf, P\
Amp, Prl, Cz, PSQ17\
SC6, SH30, SH31\
SH8, SC14, BC150.83\
2.50\
2.500.13Cz, Kf, P\
Amp, Cz, PSC21, BC21\
SC4, BC6, SC7, SC8, BC7, SQ9, SC9, BC11, BC14, BC18, SH21, BC19, SH24, SQ20, SH27, SQ25, SH29, BC26, SC23, SC25, SC281.67\
17.500.08Kf, P\
Cxm, P\
Cz, P\
Amp, PSC18\
SH7\
SH10, SH22, SH23, SC27\
BC9, SH12, SC16, SH26, BC24, SQ280.83\
0.83\
3.33\
5.000.04PSC5, BC8, SQ16, SQ18, SQ19, BC20, SC20, SC22, SQ27, BC28, BC319.17[^1]

4. Discussion {#s0055}
=============

The prevalence of *V. parahaemolyticus* in different types of seafood samples ranged from 80 to 91.43% with an average of 85.71% in this study. Blood clam was detected at the highest prevalence rate (91.43%) followed by shrimp (88.57%), surf clam (82.86%), and squid (80.00%). The higher occurrence of *V. parahaemolyticus* in seafood was mainly due to the widely disseminated of *V. parahaemolyticus* in estuarine, marine and coastal environments ([@b0235], [@b0095], [@b0070], [@b0280]). The warm and tropical climate of Malaysia is also likely to promote and favour the growth of *V. parahaemolyticus*. [@b0220] reported that the warmer the weather, the higher the incidence density of gram-negative bacteria. Not only that, [@b0230] reported that an average temperature increases by 3.7 °C could lead to the changes in the concentration of *V. parahaemolyticus* and increase the risk of illness by two to three times higher.

The results obtained from this study were found to be comparable to the findings of [@b0265]. [@b0265] reported that 332 of 385 (86.2%) seafood samples, including molluscan shellfish and shrimp collected in Vietnam, had been contaminated with *V. parahaemolyticus*. On the other hand, [@b0165] reported a slightly higher prevalence of *V. parahaemolyticus* in seafood samples where all blood clams (84/84), 98.7% (75/76) surf clams, and 97.2% (70/72) shrimps were positive for *V. parahaemolyticus*. In contrast, [@b0140] reported only 44% (200/450) shellfish samples, including mud crab, flower crab, carpet clam, hardshell clam, and mud creeper collected in Malaysia, were found to be positive for *V. parahaemolyticus* species-specific *toxR* gene. Similarly, [@b0150] reported a low prevalence rate of *V. parahaemolyticus* in which 15.7% (365/2328) fish, 27.6% (164/594) crustaceans and 27.6% (84/304) molluscs collected in China were identified for *V. parahaemolyticus.*

Although a high prevalence of *V. parahaemolyticus* was detected in seafood samples, the majority of isolates were found to be non-pathogenic to humans due to lack of pathogenic *tdh* and *trh* genes. In this study, no seafood samples were detected with *tdh* and/or *trh* genes. Previous studies have also reported a low occurrence of *V. parahaemolyticus* isolates for *tdh* and *trh* genes, in accordance with the present results. [@b0265] reported that 25 out of 385 (6.5%) molluscan shellfish and shrimp samples were detected with pathogenic *tdh* and/or *trh* genes. [@b0165] revealed that 33.1% (77/232) and 6.9% (16/232) of seafood samples were detected with the presence of *tdh* and *trh* genes, respectively. [@b0140] reported that only 6.5% (13/200) of the *V. parahaemolyticus* isolates collected from shellfish samples were *trh*-positive and none of the samples was *tdh*-positive. Consequently, majority of *V*. *parahaemolyticus* strains isolated from the seafood samples are found with the absence of *tdh* and *trh* genes. However, the pathogenicity of *V. parahaemolyticus* is complex and interactive ([@b0245]). The significance of *V. parahaemolyticus* and its host-pathogen interactions for human infection is still questionable ([@b0065]). *V. parahaemolyticus* strain without the virulence *tdh* and *trh* genes have been also isolated from clinical specimens and reported in several studies ([@b0040], [@b0100], [@b0145], [@b0210]). Besides the predominant *tdh* and *trh* hemolysin genes, the other factors contributing to human pathogenesis of *V. parahaemolyticus* infection have been addressed in some previous research studies. For instance, [@b0170] suggested that the presence of Type III Secretion Systems (T3SS) in *V. parahaemolyticus* strain is one of the important virulence factors closely related to *V. parahaemolyticus* pathogenicity. Urease present in many other foodborne pathogens, including *V. parahaemolyticus*, is defined as an enterovirulence factor that hydrolyses urea and increases pH in the immediate environment within the host ([@b0200], [@b0085], [@b0030]).

*V. parahaemolyticus* isolated from different types of seafood samples in this study were found to be highly resistant to the penicillin class of antibiotics, including penicillin G (10 unit) and ampicillin (10 µg). This finding is consistent with previous studies that the majority of *V. parahaemolyticus* isolates from seafood, such as grouper, shellfish, small mackerel and shrimp, were found to be highly resistant to penicillin (92.54--100%) and ampicillin (82.09--88%) ([@b0225], [@b0140], [@b0260], [@b0015]). A total of 84.17% of *V. parahaemolyticus* isolates from this study were also found to be resistant to cefazolin (30 µg), which is a cephalosporin antibiotic. From the results, it can be concluded that *V. parahaemolyticus* strains isolated from different types of seafood were found to be highly resistant to beta-lactam class antibiotics, including penicillin and cephalosporins. Therefore, ampicillin, penicillin and cefazolin should be phased-out for treating *V. parahaemolyticus* infections. Likewise, cefotaxime and ciprofloxacin are not a good choice in the treatment regimens for *Vibrio* infections because of its associated intermediate resistance by 60% and 66.67% of *V. parahaemolyticus* isolates, respectively.

Although *V. parahaemolyticus* isolates from this study displayed high levels of resistance to ampicillin, cefazolin, and penicillin, as well as intermediate levels of resistance to cefotaxime and ciprofloxacin, the antibiogram revealed that most of the *V*. *parahaemolyticus* isolates were susceptible to ampicillin-sulbactam (93.33%), chloramphenicol (100%), doxycycline (98.33%), imipenem (98.33%), meropenem (98.33%), tetracycline (94.17%), and trimethoprim-sulfamethoxazole (95%). These findings are comparable to the results of [@b0140] in which *V. parahaemolyticus* isolates from shrimp samples were found to be highly susceptible to ampicillin-sulbactam (96%), chloramphenicol (95%), imipenem (98%), tetracycline (82%), and trimethoprim-sulfamethoxazole (93%). [@b0155] also reported that all isolates of *V*. *parahaemolyticus* isolated from raw shellfish were susceptible to chloramphenicol and tetracycline. Similarly, [@b0285] demonstrated that majority of *V. parahaemolyticus* isolates from retail aquatic products in North China were susceptible to chloramphenicol (95%), ciprofloxacin (92%), gentamicin (63%), tetracycline (83%), and trimethoprim-sulfamethoxazole (75%). These antibiotics could, therefore, be used effectively in the treatment of *V*. *parahaemolyticus* infections.

*V*. *parahaemolyticus* isolates tested in this study demonstrated MAR indices ranging from 0.04 to 0.71, with an average of 0.22. One isolate from blood clam exhibited the highest MAR index value of 0.71 which showed resistance to 17 antibiotics. Overall, 90.83% of *V*. *parahaemolyticus* isolates were multidrug resistance (MDR) which exhibited resistance to more than one antibiotic used in this study. A total 67 of 120 isolates (55.83%) had MAR indices of more than 0.20. The MAR index greater than 0.2 indicates that the bacterial strain tested originated from the high-risk sources where antibiotics are frequently used ([@b0135], [@b0075]). According to the study conducted by [@b0005] which reported all *V*. *parahaemolyticus* isolates showed MDR for at least 7 antibiotics, MAR indices ranging from 0.58 to 1, and an average MAR index value of 0.77. [@b0295] showed the MAR indices ranging from 0.11 to 0.22 and *V*. *parahaemolyticus* isolate with the highest MAR index exhibited resistance to 4 antibiotics. From these results, it is noted that MAR indices vary between the studies and are not suitable for comparison due to the number of antibiotics and types of antibiotics used in the tests.

5. Conclusion {#s0060}
=============

High prevalence of *V*. *parahaemolyticus* was detected in various types of seafood samples collected in Selangor, Malaysia. Although pathogenic *V*. *parahaemolyticus* strains with hemolysin *tdh* and *trh* genes have not been detected in this study, the risk of *V*. *parahaemolyticus* infection cannot be disregarded as the pathogenesis of vibriosis caused by *tdh*- and *trh*-negative strains of *V. parahaemolyticus* is still open to question. Infections caused by multidrug-resistant *V*. *parahaemolyticus* strains also pose a significant risk to human health. Antimicrobial resistance surveillance programmes should be continuous and aggregated at the national level in order to detect the emerging resistance and access the burden of antimicrobial resistance.
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[^1]: BC -- Blood clam; SH -- Shrimp; SC -- Surf clam; SQ -- Squid.
